Metsera, Inc., a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today announced positive topline results from the Phase 1 ...
Recently debuted Metsera is unfolding some phase 1 data for its GLP-1 receptor agonist, revealing a 7.5% reduction in body ...
Chad Jessup, who previously worked on Destiny 2 expansions and the Xbox 360 version of Shadowrun, posted about emptying his ...